Ildong Pharmaceutical Co., Ltd. (KRX:249420)

Ildong Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jan 29, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	1,198,882	328,764	502,483	764,721	799,187	449,542
Market Cap Growth	265.91%	-34.57%	-34.29%	-4.31%	77.78%	18.46%
Enterprise Value	1,296,546	467,886	480,579	872,139	869,595	531,687
Last Close Price	38050.00	11770.00	18160.00	28550.00	33600.00	18900.00
PE Ratio	38.79	-	-	-	-	-
Forward PE	27.88	14.76	14.76	14.76	14.76	14.76
PS Ratio	2.08	0.54	0.84	1.20	1.43	0.80
PB Ratio	5.12	1.98	2.80	3.75	4.79	1.77
P/TBV Ratio	5.74	2.48	3.75	4.96	7.37	2.08
P/FCF Ratio	179.59	18.67	-	-	-	89.66
P/OCF Ratio	57.28	11.62	-	-	-	23.21
PEG Ratio	-	0.32	0.32	0.32	0.32	0.32
EV/Sales Ratio	2.25	0.76	0.80	1.37	1.55	0.95
EV/EBITDA Ratio	30.21	12.52	-	-	-	16.02
EV/EBIT Ratio	68.62	40.93	-	-	-	96.16
EV/FCF Ratio	194.22	26.56	-	-	-	106.04
Debt / Equity Ratio	0.66	1.24	1.19	1.02	1.36	0.66
Debt / EBITDA Ratio	3.63	5.50	-	-	-	5.03
Debt / FCF Ratio	23.28	11.67	-	-	-	33.28
Asset Turnover	0.99	1.02	0.95	0.94	0.85	0.92
Inventory Turnover	3.76	4.42	4.23	4.44	3.97	4.07
Quick Ratio	0.48	0.52	0.41	0.44	0.59	0.74
Current Ratio	0.94	0.92	0.69	0.91	0.84	1.26
Return on Equity (ROE)	10.56%	-7.17%	-42.25%	-76.68%	-47.91%	-5.13%
Return on Assets (ROA)	2.01%	1.19%	-5.27%	-6.75%	-5.17%	0.57%
Return on Invested Capital (ROIC)	5.72%	3.82%	-16.60%	-25.79%	-18.97%	1.67%
Return on Capital Employed (ROCE)	5.60%	3.60%	-19.80%	-21.30%	-15.50%	1.30%
Earnings Yield	2.33%	-1.39%	-15.71%	-18.52%	-12.48%	-2.90%
FCF Yield	0.56%	5.36%	-9.91%	-8.55%	-3.25%	1.11%
Payout Ratio	0.22%	-	-	-	-	-
Buyback Yield / Dilution	-2.17%	-3.34%	-2.61%	-10.76%	0.00%	0.02%
Total Shareholder Return	-2.17%	-3.34%	-2.61%	-10.76%	0.00%	0.02%

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.